Quantcast

Latest Parkinson's disease Stories

2014-03-28 16:22:24

Supports Partnerships Between Patient Advocates and Scientists at Four Leading Parkinson's Research Centers NEW YORK, March 28, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Disease Foundation® (PDF®) is pleased to announce $20,000 in grant funding to support patient-centered research at four leading Parkinson's disease research institutions. The grants are provided through PDF's first Parkinson's Advocates in Research (PAIR) Leadership Awards. These awards support partnerships...

2014-03-28 13:39:33

A new chemical messenger that is critical in protecting the brain against Parkinson's disease has been identified by scientists at the Medical Research Council (MRC) Protein Phosphorylation and Ubiquitylation Unit at the University of Dundee. The research team led by Dr Miratul Muqit had previously discovered that mutations in two genes – called PINK1 and Parkin – lead to Parkinson's. Now they have made a completely unexpected discovery about the way the two genes interact, which...

2014-03-26 12:28:27

Biomedical research institute appoints two key positions, expanding its impact on neurodegenerative science GRAND RAPIDS, Mich., March 26, 2014 /PRNewswire/ -- Van Andel Research Institute's Center for Neurodegenerative Science continues to expand its research portfolio and increase its impact in the field of Parkinson's disease research. The Center recently appointed Dr. Jiyan Ma, whose laboratory studies prions, the misfolded proteins associated with many contagious...

2014-03-25 08:31:05

--Funds Will Advance Novel Approach for Treatment of Alzheimer's Disease and Other Diseases of Protein Aggregation-- CAMBRIDGE, Mass., March 25, 2014 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc. today announced the completion of a $17 million Series D financing from existing and new investors to advance the Company's lead candidate, NPT088, and potential next-generation compounds toward clinical trials. NPT088 has the potential to treat a wide range of neurodegenerative diseases,...

2014-03-23 23:04:12

Understanding Essential Tremor: The Diagnosis Process and Treatment Options Lenexa, KS (PRWEB) March 23, 2014 The International Essential Tremor Foundation (IETF) will host a free seminar in Cleveland, Ohio on the life-altering neurological condition called essential tremor (ET). The seminar will take place on Saturday, April 5, 2014 at the Cleveland Airport Marriott located at 4277 West 150th Street. The program will run from 9:30 to 11:30 a.m., with a question and answer session with...

2014-03-21 23:01:42

Many living with Parkinson’s Disease are at their wit’s end as they face their medication’s dosage limits and there are no longer any measurable differences in their symptoms. When typical Parkinson’s Treatment paths are completely exhausted, patients begin to turn to alternative methods to control their symptoms so that they can regain some semblance of daily living without discomfort (or near as much). (PRWEB) March 21, 2014 Parkinson’s Disease is a degenerative disorder of...

2014-03-18 23:03:24

Transparency Market Research Report published "Deep Brain Stimulation Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019" to its database. Browse the report with Full TOC at http://www.transparencymarketresearch.com/deep-brain-stimulator-market.html. Albany, New York (PRWEB) March 18, 2014 According to a new market report published by Transparency Market Research "Deep Brain Stimulation Devices Market for Parkinson's...

2014-03-18 08:31:38

ALBANY, New York, March 18, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia-Pacific and Latin America)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global deep brain stimulation devices market was valued at USD 4.5 billion in 2012 and is expected to grow at a CAGR of 11.0% from 2013 to 2019, to...

2014-03-13 16:27:32

Research Areas Chosen by People with Parkinson's through PDF Community Choice Research Awards NEW YORK, March 13, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Disease Foundation® (PDF®) is pleased to announce $30,000 in funding to address two disabling, yet under-recognized symptoms of Parkinson's disease - fatigue and gastrointestinal dysfunction - through its first Community Choice Research Awards. The patient community identified these two areas as priorities for scientific...

2014-03-11 08:29:26

REHOVOT, Israel, March 11, 2014 /PRNewswire/ -- NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its second Phase II clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formulation under development for continuous subcutaneous administration through a patch pump. It is designed to provide steady levodopa blood levels for the treatment of Parkinson's disease....


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.